Table S1. Adjusted estimates for the effect of baseline risk factors on cardiovascular mortality from Cox-PH, Lunn-McNeil and Fine-Gray Models. (DOCX 15 kb
Table S1. Baseline clinical features in the RIACE participants with valid information on vital statu...
Figure S1. Cumulative survival by Kaplan Meier analysis according to BP status, based on the 130/80â...
Table S1. Clinical characteristics of patients at baseline and at 4-year grouped by of basal GFR. (D...
Table S2. Adjusted estimates for the effect of baseline risk factors on cancer mortality from Cox-PH...
Figure S3. Proportional cause-specific hazards assessment for other mortality. (PDF 1695 kb
Figure S4. Proportional subdistribution hazards assessment for cardiovascular mortality. (PDF 1100 k...
Figure S5. Proportional subdistribution hazards assessment for cancer mortality. (PDF 865 kb
Supplementary Material 1: Figure S1. Flowchart of the current study. Table S1. Hazard ratios (HR) an...
Table S2. Baseline clinical characteristics of patients grouped by eGFR and albuminuria. (DOCX 19 kb
Table S1. Multivariable-adjusted hazard ratios of atherosclerotic cardiovascular composite endpoints...
Table S2. Odds ratios for clinical factors associated with the presence of sarcopenia according to a...
Figure S1. Sensitivity analysis. Sensitivity analyses were performed to evaluate the influence of a ...
Table S1.Baseline characteristics for all patients in the original cohort. Data are means and SD (st...
Additional file 1: Table S1. Test of Likelihood ratio for interaction term. Table S2. Test of propor...
The biomarker hazard ratios using Cox proportional hazards models that included GN vs non-GN CKD and...
Table S1. Baseline clinical features in the RIACE participants with valid information on vital statu...
Figure S1. Cumulative survival by Kaplan Meier analysis according to BP status, based on the 130/80â...
Table S1. Clinical characteristics of patients at baseline and at 4-year grouped by of basal GFR. (D...
Table S2. Adjusted estimates for the effect of baseline risk factors on cancer mortality from Cox-PH...
Figure S3. Proportional cause-specific hazards assessment for other mortality. (PDF 1695 kb
Figure S4. Proportional subdistribution hazards assessment for cardiovascular mortality. (PDF 1100 k...
Figure S5. Proportional subdistribution hazards assessment for cancer mortality. (PDF 865 kb
Supplementary Material 1: Figure S1. Flowchart of the current study. Table S1. Hazard ratios (HR) an...
Table S2. Baseline clinical characteristics of patients grouped by eGFR and albuminuria. (DOCX 19 kb
Table S1. Multivariable-adjusted hazard ratios of atherosclerotic cardiovascular composite endpoints...
Table S2. Odds ratios for clinical factors associated with the presence of sarcopenia according to a...
Figure S1. Sensitivity analysis. Sensitivity analyses were performed to evaluate the influence of a ...
Table S1.Baseline characteristics for all patients in the original cohort. Data are means and SD (st...
Additional file 1: Table S1. Test of Likelihood ratio for interaction term. Table S2. Test of propor...
The biomarker hazard ratios using Cox proportional hazards models that included GN vs non-GN CKD and...
Table S1. Baseline clinical features in the RIACE participants with valid information on vital statu...
Figure S1. Cumulative survival by Kaplan Meier analysis according to BP status, based on the 130/80â...
Table S1. Clinical characteristics of patients at baseline and at 4-year grouped by of basal GFR. (D...
DOI
Add to ORKG